Primary Sjögren’s syndrome with pulmonary embolism:a case report and literature review

doi:10.3969/j.issn.1004-583X.2021.04.015

Abstract

Abstract:

This study analyzed the data of a patient with primary Sjögren's syndrome (pSS)complicated with pulmonary embolism admitted to the Yanan University Affiliated Hospital, and reviewed the relevant literature.If SS Patients, who were also related to the respiratory system or active inflammation, are encountered in clinical, they should be vigilant and memorize the differential diagnosis of SS pulmonary manifestations. CT angiography(CTA) should be performed as soon as possible for patients with multiple risk factors or high risk of pulmonary embolism. Thrombosis might be caused by pulmonary infection or inflammatory activity of primary disease.

Key words: Sjögren’s syndrome, pulmonary embolism, thrombus

CLC Number:

R777.2

Cui Lu, Li Jing, Liu Yuhong. Primary Sjögren’s syndrome with pulmonary embolism:a case report and literature review[J]. Clinical Focus, 2021, 36(4): 361-364.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.04.015

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I4/361

Figures/Tables 3

References 23

[1]	Ibrahem HM. B cell dysregulation in primary Sjögren's syndrome: A review[J]. Jpn Dent Sci Rev, 2019,55(1):139-144. doi: 10.1016/j.jdsr.2019.09.006 URL
[2]	Sebastian A, Misterska-Skora M, Silicki J, et al. Chest HRCT findings in patients with primary Sjogren's syndrome[J]. Adv Clin Exp Med, 2017,26(7):1101-1106. doi: 10.17219/acem/68978 pmid: 29211358
[3]	Gao H, Zhang XW, He J, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study[J]. Medicine (Baltimore), 2018,97(24):e11003. doi: 10.1097/MD.0000000000011003 URL
[4]	Flament T, Bigot A, Chaigne B, et al. Pulmonary manifestations of Sjogren's syndrome[J]. Eur Respir Rev, 2016,25(140):110-23. doi: 10.1183/16000617.0011-2016 pmid: 27246587
[5]	Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjogren's syndrome: Underlying immunological mechanisms, clinical presentation, and management[J]. Front Immunol, 2019,10:1327. doi: 10.3389/fimmu.2019.01327 URL
[6]	Heus A, Arends S, Van Nimwegen JF, et al. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI[J]. Scand J Rheumatol, 2020,49(1):38-46. doi: 10.1080/03009742.2019.1634221 pmid: WOS:000488078900001
[7]	Kampolis CF, Fragkioudaki S, Mavragani CP, et al. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren's syndrome[J]. Clin Exp Rheumatol, 2018, 36 Suppl 112(3): 94-101. doi: <空> pmid: WOS:000446486100014
[8]	Schreiber K, Sciascia S, de Groot PG, et al. Antiphospholipid syndrome[J]. Nat Rev Dis Primers, 2018,4:17103. doi: 10.1038/nrdp.2017.103 pmid: 29321641
[9]	Mezhov V, Segan JD, Tran H, et al. Antiphospholipid syndrome: a clinical review[J]. Med J Aust, 2019,211(4):184-188. doi: 10.5694/mja2.v211.4 URL
[10]	Lee JJ, Pope JE. Pope.A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases[J]. Arthritis Res Ther, 2014,16(5):435. doi: 10.1186/s13075-014-0435-y URL
[11]	Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study[J]. J Rheumatol, 2014,41(5):909-915. doi: 10.3899/jrheum.131345 URL
[12]	Avina-Zubieta JA, Jansz M, Sayre EC, et al. The risk of deep venous thrombosis and pulmonary embolism in primary Sjogren syndrome: a general population-based study[J]. J Rheumatol, 2017,44(8):1184-1189. doi: 10.3899/jrheum.160185 URL
[13]	Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of venous thromboembolism in patients with Sjogren's syndrome: a systematic review and meta-analysis[J]. Clin Exp Rheumatol, 2015,33(5):746-750. pmid: 26087815
[14]	Zhang YF, Lu YW. Clinical features of patients with primary Sjogren's syndrome complicated with venous thrombosis[J]. Zhonghua Yi Xue Za Zhi, 2018,98(39):3197-3199.
[15]	Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism[J]. Front Pediatr, 2018,6:142. doi: 10.3389/fped.2018.00142 pmid: 29876337
[16]	Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: Cause or consequence?[J]. Int Immunopharmacol, 2015,28(1):655-665. doi: 10.1016/j.intimp.2015.07.044 URL
[17]	Saghazadeh A, Rezaei N. VInflammation as a cause of venous thromboembolism[J]. Crit Rev Oncol Hematol, 2016,99:272-285. doi: 10.1016/j.critrevonc.2016.01.007 URL
[18]	Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018,16(2):231-241. doi: 10.1111/jth.13911 pmid: 29193703
[19]	Olson NC, Cushman M, Lutsey PL, et al. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort[J]. J Thromb Haemost, 2014,12(12):1993-2001. doi: 10.1111/jth.12742 pmid: 25292154
[20]	Branchford BR, Carpenter SL. The Role of inflammation in venous thromboembolism[J]. Front Pediatr, 2018,6:142. doi: 10.3389/fped.2018.00142 pmid: 29876337
[21]	Baldini C, Zabotti A, Filipovic N, et al. Imaging in primary Sjögren's syndrome: the 'obsolete andthe new'[J]. Clin Exp Rheumatol, 2018, 36 Suppl 112(3): 215-221.
[22]	Bjordal O, Norheim KB, Rødahl E, et al. Primary Sjögren's syndrome and the eye[J]. Surv Ophthalmol, 2020,65(2):119-132. doi: 10.1016/j.survophthal.2019.10.004 URL
[23]	Mavragani CP, Moutsopoulos HM. Sjögren's syndrome: Old and new therapeutic targets[J]. J Autoimmun, 2020,110:102364. doi: 10.1016/j.jaut.2019.102364 URL